Pesquisas alternativas:
families derived » families bereaved (Expandir a Pesquisa), families during (Expandir a Pesquisa)
drug families » young families (Expandir a Pesquisa), drug family (Expandir a Pesquisa), drug facility (Expandir a Pesquisa)
derived ther » derived rather (Expandir a Pesquisa), derived three (Expandir a Pesquisa), derived thin (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
families derived » families bereaved (Expandir a Pesquisa), families during (Expandir a Pesquisa)
drug families » young families (Expandir a Pesquisa), drug family (Expandir a Pesquisa), drug facility (Expandir a Pesquisa)
derived ther » derived rather (Expandir a Pesquisa), derived three (Expandir a Pesquisa), derived thin (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
1
“...Artemisinin and its derivatives are the first-line antimalarial drugs, and have saved millions...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
3
Por Lee, Hong-Goo, Park, Yun-Sang, Jeong, Jin-Hyuk, Kwon, Yong-Bin, Shin, Dae Hwan, Kim, Ju-Young, Rhee, Yun-Seok, Park, Eun-Seok, Kim, Dong-Wook, Park, Chun-Woong
Publicado no Drug Des Devel Ther (2019)
“... to commercial reference tablets Toviaz and Betmiga, based on a satisfactory similarity factor. Drug-release...”Publicado no Drug Des Devel Ther (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Kim, Yo Han, Choi, Hee Youn, Noh, Yook-Hwan, Lee, Shi Hyang, Lim, Hyeong-Seok, Kim, Chin, Bae, Kyun-Seop
Publicado no Drug Des Devel Ther (2015)
“... of the carvedilol sustained-release (SR) formulation in healthy male subjects. METHODS: An open-label, single dose...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
6
Por Bandinelli, Francesca, Scazzariello, Francesco, Pimenta da Fonseca, Emanuela, Barreto Santiago, Mittermayer, Marcassa, Claudio, Nacci, Francesca, Matucci Cerinic, Marco
Publicado no Drug Des Devel Ther (2016)
“...-release prednisone taken in the morning. The efficacy of low-dose MR prednisolone in patients with SpA...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Park, Gab-jin, Bae, Soo Hyeon, Park, Wan-Su, Han, Seunghoon, Park, Min-Ho, Shin, Seok-Ho, Shin, Young G, Yim, Dong-Seok
Publicado no Drug Des Devel Ther (2017)
“...PURPOSE: A microdose drug–drug interaction (DDI) study may be a valuable tool for anticipating drug...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Huang, Hong, Liu, Houhe, Zhou, Hua, Liang, Zhiling, Song, Dandan, Zhang, Yun, Huang, Wanqiu, Zhao, Xiaotian, Wu, Bo, Ye, Guodong, Huang, Yugang
Publicado no Drug Des Devel Ther (2019)
“... target. CONCLUSION: It has been suggested that SAE with tranexamic acid could be a drug-release system...”Publicado no Drug Des Devel Ther (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“.... In December 2014, the US Food and Drug Administration approved Namzaric™, a once-daily, fixed-dose combination...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Miyatake, Shouta, Shimizu-Motohashi, Yuko, Takeda, Shin’ichi, Aoki, Yoshitsugu
Publicado no Drug Des Devel Ther (2016)
“... show the therapeutic potential of inhibiting or enhancing pro- or anti-inflammatory factors released...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“...This analysis evaluated the single-dose population pharmacokinetics (PK) of biphasic immediate...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Lee, Jieon, Rhee, Su-jin, Lee, SeungHwan, Yu, Kyung-Sang
Publicado no Drug Des Devel Ther (2018)
“... dose or as multiple doses to healthy Caucasians. METHODS: Thirty-six subjects were enrolled...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... bivalent inhibitor created by linking rapamycin and sapanisertib, can bind to both drug binding pockets...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
“...This study focuses on the development of a drug product based on a risk assessment-based approach...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Liu, Qingyu, He, Mengmei, Shi, Hui, Wang, Qianyi, Du, Yaru, Liu, Junling, Ren, Chengda, Xu, Ding, Yu, Jing
Publicado no Drug Des Devel Ther (2015)
“... group, the ORs for ≥15 letter improvement of visual acuity in the high-dose and low-dose groups were...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Kim, Yo Han, Ghim, Jong-Lyul, Jung, Jin Ah, Cho, Sang-Heon, Choe, Sangmin, Choi, Hee Youn, Bae, Kyun-Seop, Lim, Hyeong-Seok
Publicado no Drug Des Devel Ther (2015)
“...BACKGROUND: A new extended-release form of cilostazol has recently been developed. This study...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Chen, Laishun, Greenberg, William M, Brand-Schieber, Elimor, Wangsa, Julie, Periclou, Antonia, Ghahramani, Parviz
Publicado no Drug Des Devel Ther (2015)
“...PURPOSE: Levomilnacipran extended-release (ER) is indicated for treatment of major depressive...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Shin, Kwang-Hee, Jeon, Ji-Young, Jang, Kyungho, Kim, Tae-Eun, Kim, Min-Gul
Publicado no Drug Des Devel Ther (2018)
“...PURPOSE: The aim of this study was to evaluate the dose-proportional pharmacokinetic...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Balata, Gehan F, Essa, Ebtessam A, Shamardl, Hanan A, Zaidan, Samira H, Abourehab, Mohammed AS
Publicado no Drug Des Devel Ther (2016)
“... stability, emulsification efficiency, droplet size, zeta potential, and in vitro drug release. Self...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Hua, Dan, Kong, Weiling, Zheng, Xuemin, Zhou, Zhixing, Yu, Bing, Li, Yazhou, Wang, Yuli, Yang, Xue, Liu, Changxiao, Tang, Lida, Li, Ying, Gong, Min
Publicado em 2014
“... metalloproteinase (MMP)-2 specific targeting activity, producing a supramolecule possessing controlled drug release...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo